reputation – Talk Bio

Getting to Yes: How Deal-Making Fuels Biotech Growth – 2025 Updates

1 month ago talkbio0Tagged Acquisitions, BATNA, biotech dealmaking, Licensing, mergers, patent cliffs, pharmaceutical negotiations, pipeline gaps, regulatory uncertainty, reputation, valuation, venture capital

biotech dealmaking; mergers and acquisitions; licensing; venture capital; BATNA; pharmaceutical negotiations; reputation; pipeline gaps; patent cliffs; valuation; regulatory uncertainty

Pharmaceutical Industry’s Public Image Deteriorates Post-Pandemic Era

1 year ago talkbio0Tagged COVID19 (disease), development aspects, Drug Industry, Pandemics, Public Opinion, reputation, Vaccines

Pharmaceutical industry, reputation, pandemic, public opinion, COVID-19, vaccine development, drug pricing, transparency.

AbbVie Emerges as Leading Immunology Company in Doctor Rankings, Surpassing Pfizer and Johnson & Johnson

2 years ago talkbio0Tagged AbbVie, Drug Industry, Immunology, Johnson & Johnson, Market, Performance, Pfizer, Physicians, portfolio, product, reputation

AbbVie, Pfizer, Johnson & Johnson, doctor ranking, immunology companies, pharmaceutical industry, market performance, reputation, product portfolio.